Skip to the page

Data / Form D filings / Forcyte Biotechnologies, Inc.

Forcyte Biotechnologies, Inc.: Form D filings

Forcyte Biotechnologies, Inc., a technology company in Los Angeles, CA, filed 2 Form D notices with the SEC in 2019. The latest, on January 15, 2019, reports $160,000 sold of a $2 million offering to 3 investors.

Find out what Forcyte Biotechnologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11957 DARLINGTON AVENUE, 202, Los Angeles, CA, 90049
Phone
(859) 420-4398
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2017
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1760069

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 15, 2019Amendment$2,000,000$160,000$1,840,0003Dec 18, 2018sec.gov
Jan 10, 2019New notice$2,000,000$1,000,000$1,000,0003Dec 18, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ivan PushkarskyExecutive Officer

Other technology companies in California that filed recently

Every Form D from the week of Jan 14, 2019 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Forcyte Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.